Posts by: Leonor Mateus Ferreira

Leonor Mateus Ferreira

Leonor Mateus Ferreira is an emerging, young journalist, with a Batchelor's degree in Communication and post-graduate degree in Multiplatform Journalism. She is particularly interested in politics and current affairs, and is currently studying for a masters degree in economics and public policies.

September 15, 2014November 11, 2015

Wearable, Comfortable COPD Breathing Device Gets Key Endorsements

COPD, News

California-based Breathe Technologies was recently granted CE Certification for its Non-Invasive Open Ventilation (NIOV) System, a medical technology for patients with respiratory insufficiency diseases and neuromuscular diseases, which will allow the company to market ... Read more

September 12, 2014November 6, 2015

Pharmaxis to Present New Data on Bronchiectasis Study at European Respiratory Society

Bronchiectasis

Pharmaceutical company Pharmaxis announced that it has presented new data from its large scale study of Bronchitol, called B305, and conducted in patients with bronchiectasis, at the European Respiratory Society (ERS), which took take ... Read more

September 10, 2014November 6, 2015

Aradigm’s Novel Non-Cystic Fibrosis Bronchiectasis Treatment Granted Fast Track Status by FDA

Bronchiectasis, News

The pharmaceutical company Aradigm Corporation received Fast Track status for its lead product candidate, Pulmaquin, from the U.S. Food and Drug Administration. The drug, which is being studied for treatment of non-cystic ... Read more

August 28, 2014November 11, 2015

Pharmaxis Ready to Start Test COPD and NASH Treatment on Humans

COPD, News

The chronic respiratory disorders pharmaceutical specialist Pharmaxis completed the development of its experimental drug, the Semicarbazide-Sensitive Amine Oxidase/Vascular Adhesion Protein-1 (SSAO/VAP-1) Inhibitor (PXS4728A), which is designed to treat several forms of chronic inflammation ... Read more

August 25, 2014August 25, 2014

American Lung Association Advises Adult Lung Disease Patients To Get Vaccinated

News

The American Lung Association is advising adults, especially ones who suffer from lung diseases, to consider consulting with their healthcare providers on getting vaccinations, since not only children but also adults can ... Read more

August 22, 2014November 6, 2015

FDA Approves GSK’s Drug Arnuity Ellipta to Treat Asthma in the US

Asthma

The U.S. Food and Drug Administration recently approved GlaxoSmithKline‘s treatment of asthma, Arnuity Ellipta (fluticasone furoate inhalation powder), as a prophylactic therapy in patients aged 12 years and older. Arnuity Ellipta is a once-daily ... Read more

August 21, 2014November 6, 2015

Novel Vectura Asthma Monotherapy Now in Full Development

Asthma, News

Investors on Wall Street have responded positively to a recent US collaboration, development, and license agreement established by the Vectura Group, a respiratory product development company, for the development of its clinical ... Read more

August 5, 2014November 6, 2015

Aradigm Doses First Patient in Second Phase III Study of Pulmaquin in Non-Cystic Fibrosis Bronchiectasis

Bronchiectasis, News

Aradigm Corporation announced the dosing of the first patient in a Phase III pivotal clinical trial that is testing Pulmaquin, an inhaled ciprofloxacin formula. ORBIT-4 is the second of two trials ... Read more

August 4, 2014August 4, 2014

Memorial Hermann Starts New Lung Cancer Screening Program For At-Risk Patients

Lung Cancer

Memorial Hermann Katy Hospital recently launched a new Lung Cancer Screening Program meant to help patients who are at high risk for lung cancer detect lung nodules and potential lung cancer at ... Read more

July 31, 2014November 11, 2015

Domainex’s COPD Drug Reveals Double Effectiveness in Clinical Trials

COPD, News

The British drug developer Domainex announced that the lead compound of their first-in-class small-molecule inhibitor has been shown to be more effective than either roflumulast or p38 inhibitors in a key model ... Read more